Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
879 JPY | +0.11% |
|
-0.57% | +15.51% |
Business Summary
Number of employees: 988
Sales per Business
JPY in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
71.6
%
| 22,723 | 67.9 % | 25,942 | 71.6 % | +14.17% |
Limulus Amebocyte Lysate
28.4
%
| 10,732 | 32.1 % | 10,271 | 28.4 % | -4.30% |
Sales per region
JPY in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Japan
38.9
%
| 13,408 | 40.1 % | 14,101 | 38.9 % | +5.17% |
United States
35.2
%
| 12,133 | 36.3 % | 12,750 | 35.2 % | +5.09% |
Other Regions
23.5
%
| 6,844 | 20.5 % | 8,508 | 23.5 % | +24.31% |
North America
2.4
%
| 1,071 | 3.2 % | 854 | 2.4 % | -20.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ken Mizutani
PSD | President | 76 | 88-07-31 |
Takayuki Akita
ADM | Chief Administrative Officer | 60 | 17-05-31 |
Yosuke Funakoshi
CTO | Chief Tech/Sci/R&D Officer | 58 | 14-07-31 |
Toshiyuki Okada
BRD | Director/Board Member | 63 | 15-08-31 |
Atsushi Hariu
IRC | Investor Relations Contact | - | - |
Daisuke Sugiyama
AUD | Comptroller/Controller/Auditor | - | - |
Hiroyuki Konishi
HRO | Human Resources Officer | - | - |
Susumu Ito
PRN | Corporate Officer/Principal | - | - |
Shigeru Kawahara
AUD | Comptroller/Controller/Auditor | 64 | 08-04-30 |
Toru Takeda
AUD | Comptroller/Controller/Auditor | 64 | 16-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Mizutani
PSD | President | 76 | 88-07-31 |
Eiji Katayama
BRD | Director/Board Member | 73 | 97-05-31 |
Toshiyuki Okada
BRD | Director/Board Member | 63 | 15-08-31 |
Yosuke Funakoshi
CTO | Chief Tech/Sci/R&D Officer | 58 | 14-07-31 |
Takayuki Akita
ADM | Chief Administrative Officer | 60 | 17-05-31 |
Mio Minaki
BRD | Director/Board Member | 51 | 19-06-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 56,814,093 | 35,154,347 ( 61.88 %) | 2,253,745 ( 3.967 %) | 61.88 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
SEIKAGAKU CORPORATION 3.97% | 2,253,600 | 3.97% | 12,314,527 $ |
502,500 | 1.09% | 12,026,765 $ | |
1,130,000 | 0.31% | 11,548,679 $ | |
665,000 | 0.24% | 4,654,920 $ | |
121,400 | 0.59% | 4,135,720 $ | |
259,700 | 0.00% | 2,791,380 $ | |
TECHNO RYOWA LTD. 0.21% | 49,170 | 0.21% | 518,721 $ |
24,040 | 0.00% | 501,842 $ | |
63,180 | 0.01% | 246,027 $ | |
3,700 | 0.00% | 98,860 $ |
Company contact information
Seikagaku Corp.
Marunouchi Center Building, 10/F 1-6-1 Marunouchi
100-0005, Tokyo
+
http://www.seikagaku.co.jp![address Seikagaku Corporation(4548)](https://cdn.zonebourse.com/static/address/6492182.png)
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.51% | 298M | |
+56.89% | 823B | |
+40.75% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.98% | 239B | |
+13.81% | 220B | |
-0.53% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- 4548 Stock
- Company Seikagaku Corporation